Bita Mesgarpour
Overview
Explore the profile of Bita Mesgarpour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khosravi Shadmani F, Moradi G, Naghipour M, Asadi F, Ahmadi A, Mirahmadizadeh A, et al.
Front Immunol
. 2024 Sep;
15:1420651.
PMID: 39234259
Introduction: This study measures the COVID-19 vaccine effectiveness (CVE) against hospital admission and severe COVID-19. Methods: This study is a test-negative case-control design using data from eight provinces in April,...
2.
Zare P, Poustchi H, Mohammadi Z, Mesgarpour B, Akbari M, Kamalipour A, et al.
Res Social Adm Pharm
. 2024 Aug;
20(11):1038-1046.
PMID: 39098543
Polypharmacy, defined here as the concomitant use of five or more medications, is a significant health issue, particularly affecting individuals with chronic diseases like hypertension (HTN). To compare individuals with...
3.
Abdipour Mehrian S, Ghahramani Z, Akbari M, Hashemi E, Shojaeefard E, Malekzadeh R, et al.
Arch Iran Med
. 2024 Jul;
27(7):364-370.
PMID: 39072384
Background: Drug data has been used to estimate the prevalence of chronic diseases. Disease registries and annual surveys are lacking, especially in less-developed regions. At the same time, insurance drug...
4.
Mesgarpour B, Faridfar S, Rezaei M, Abdollahiasl A, Shadnia S, Mahdavinejad A, et al.
BMC Pharmacol Toxicol
. 2024 Jul;
25(1):37.
PMID: 38951926
Background: We investigated acute poisonings resulting from medications affecting the nervous system and illicit substances at Loghman Hakim Hospital in Tehran. Methods: We retrospectively reviewed patient records at Iran's largest...
5.
Ghamar-Shooshtari A, Rahimian Z, Poustchi H, Mohammadi Z, Mesgarpour B, Akbari M, et al.
BMC Gastroenterol
. 2023 Dec;
23(1):439.
PMID: 38097949
Background: Gastroesophageal Reflux Disease (GERD) is a common chronic condition. Its chronic nature may affect the pattern of medication use. This study aimed to investigate the prevalence, associated factors, and...
6.
Lopes L, Moga D, Dal Pizzol T, Gisev N, Mesgarpour B, Berard A
Front Pharmacol
. 2023 Sep;
14:1278768.
PMID: 37771724
No abstract available.
7.
Akbari M, Kamalipour A, Pakroo M, Mesgarpour B, Poustchi H, Mohammadi Z, et al.
Arch Iran Med
. 2023 Aug;
26(3):156-165.
PMID: 37543938
Background: Although polypharmacy is considered a major predictor of irrational use of drugs, little is known about polypharmacy in developing regions. We aimed to indicate the prevalence and correlates of...
8.
Shahraz S, Shahin S, Farzi Y, Modirian M, Shahbal N, Azmin M, et al.
Arch Iran Med
. 2023 Aug;
26(3):126-137.
PMID: 37543935
Background: Assessment of quality and cost of medical care has become a core health policy concern. We conducted a nationwide survey to assess these measures in Iran as a developing...
9.
Sofi-Mahmudi A, Shamsoddin E, Ghasemi P, Nasser M, Mesgarpour B
Med J Islam Repub Iran
. 2023 Jun;
37:36.
PMID: 37284693
Background: Lockdowns due to the coronavirus disease 2019 (COVID-19) pandemic forced many dental offices to be closed. This study aims to investigate the association between COVID-19 imposed lockdowns and online...
10.
Mesgarpour B, Sadeghirad B
Clin Orthop Relat Res
. 2022 Dec;
481(1):17-24.
PMID: 36473112
No abstract available.